Kropz PLC

Elandsfontein Update regarding Water Tribunal

RNS Number : 2124M
Kropz PLC
20 January 2021

20 January 2021

Kropz Plc
("Kropz" or the "Company")

Elandsfontein Update regarding Water Tribunal ("Tribunal")

Kropz Plc (AIM: KRPZ), an emerging African phosphate explorer and developer, advises that, further to the announcement on 3 September 2020,  it has been notified that the hearing against Elandsfontein's valid integrated water use licence ("WUL") has been rescheduled for four days, commencing on 1 February 2021. The Tribunal will be resumed following a postponement in March 2020, ordered by the Chairperson of the Tribunal, following COVID-19 concerns.

The Company would like to advise the market that, in order to allow the Tribunal the appropriate opportunity to fully review the matter, it will not be providing further comment on the official proceedings until the Tribunal has announced its decision. The timing of the decision is currently unknown.

Pending the Tribunal's decision, there is no legal impediment to the continuation of the water use activities authorised in the WUL.


For further information visit or contact:


Kropz Plc


Mark Summers (CEO)

+27 (0)79744 8708



Grant Thornton UK LLP

Nominated Adviser

Samantha Harrison

Harrison Clarke

+44 (0) 20 7383 5100



Hannam & Partners


Andrew Chubb

Ernest Bell

 +44 (0)20 7907 8500



Financial PR & IR (UK)

Emily Moss

Jos Simson

Oliver Lamb

+44 (0) 207 920 3150

[email protected]


R&A Strategic Communications

PR (South Africa)

James Duncan

+27 (0)11 880 3924

[email protected] 


About Kropz Plc

Kropz is an emerging African phosphate explorer and developer, with an advanced stage phosphate mining project in South Africa and a phosphate project in the Republic of Congo. The vision of the Group is to become a leading independent phosphate rock producer and to develop into an integrated, mine-to-market plant nutrient company focusing on sub-Saharan Africa.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.